Efficacy and Safety of Coadministration of Rosuvastatin , Ezetimibe , and Colestimide in Heterozygous Familial Hypercholesterolemia
Aggressive low-density lipoprotein (LDL) cholesterol-lowering therapy is important for high-risk patients. However, sparse data exist on the impact of combined aggressive LDL cholesterol-lowering therapy in familial hypercholesterolemia (FH), particularly on…